摘要
MicroRNA (miRNA) 是包含大约 22 个核苷酸的非编码 RNA,在脊椎动物和植物中表达。它们充当转录后基因表达调节剂,微调不同细胞类型中的各种生物过程。有新的证据表明它们在动脉粥样硬化的不同阶段中的作用。除了调节参与动脉粥样硬化的炎症细胞外,miRNAs 在动脉粥样硬化的病理生理学中发挥着重要作用,例如内皮细胞 (EC) 功能障碍、血管平滑肌细胞 (VSMC) 的异常功能和胆固醇代谢。此外,miRNAs 参与动脉粥样硬化斑块发展的几种致病途径,包括它们对免疫细胞信号受体和脂质摄取的影响。在这项研究中,我们回顾了我们目前对 miRNA 在动脉粥样硬化发展的各种致病途径中的调节作用的认识,并概述了 miRNA 在动脉粥样硬化中的潜在临床应用。
关键词: MicroRNA,动脉粥样硬化,炎症,临床应用,免疫细胞,内皮细胞 (EC)。
图形摘要
Current Drug Targets
Title:Implications of microRNAs in the Pathogenesis of Atherosclerosis and Prospects for Therapy
Volume: 22 Issue: 15
关键词: MicroRNA,动脉粥样硬化,炎症,临床应用,免疫细胞,内皮细胞 (EC)。
摘要: MicroRNAs (miRNAs) are non-coding RNAs containing around 22 nucleotides, which are expressed in vertebrates and plants. They act as posttranscriptional gene expression regulators, fine-tuning various biological processes in different cell types. There is emerging evidence on their role in different stages of atherosclerosis. In addition to regulating the inflammatory cells involved in atherosclerosis, miRNAs play fundamental roles in the pathophysiology of atherosclerosis, such as endothelial cell (EC) dysfunction, the aberrant function of the vascular smooth muscle cell (VSMC) and cholesterol metabolism. Moreover, miRNAs participate in several pathogenic pathways of atherosclerotic plaque development, including their effects on immune cell signaling receptors and lipid uptake. In this study, we review our current knowledge of the regulatory role of miRNAs in various pathogenic pathways underlying atherosclerosis development and also outline potential clinical applications of miRNAs in atherosclerosis.
Export Options
About this article
Cite this article as:
Implications of microRNAs in the Pathogenesis of Atherosclerosis and Prospects for Therapy, Current Drug Targets 2021; 22 (15) . https://dx.doi.org/10.2174/1389450122666210120143450
DOI https://dx.doi.org/10.2174/1389450122666210120143450 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Pictorial Review of Intracranial Haemorrhage Revisited
Current Medical Imaging The Importance of NAD in Multiple Sclerosis
Current Pharmaceutical Design Cerebrovascular Diseases in HIV-Infected Patients
Current HIV Research Molecular Determinants of the Cardiometabolic Phenotype
Endocrine, Metabolic & Immune Disorders - Drug Targets Randomized Clinical Stroke Trials in 2006
Current Vascular Pharmacology Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections
Current Pharmaceutical Design Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator
Current Pharmaceutical Design Protein Kinases and their Modulation in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Radiological Assessment of Giant Cell Tumour of Bone in the Sacrum: From Diagnosis to Treatment Response Evaluation
Current Medical Imaging Combination of Therapeutic Hypothermia and Other Neuroprotective Strategies after An Ischemic Cerebral Insult
Current Neuropharmacology Modeling Loss of Microvascular Wall Homeostasis during Glycocalyx Deterioration and Hypertension that Impacts Plasma Filtration and Solute Exchange
Current Neurovascular Research Cardiovascular Diseases and the Nitric Oxide Pathway
Current Vascular Pharmacology Bench to Bedside of CTLA-4: A Novel Immuno-Therapeutic Agent for Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Redox Signaling Pathways Involved in Neuronal Ischemic Preconditioning
Current Neuropharmacology Contrast-Induced Nephropathy after Endovascular Aneurysm Repair, Carotid and Peripheral Interventions
Current Vascular Pharmacology Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases
Current Neurovascular Research miR-666-3p Mediates the Protective Effects of Mesenchymal Stem Cell-derived Exosomes Against Oxygen-glucose Deprivation and Reoxygenation- induced Cell Injury in Brain Microvascular Endothelial Cells via Mitogen-activated Protein Kinase Pathway
Current Neurovascular Research The Effects of Olprinone, a Phosphodiesterase 3 Inhibitor, on Systemic and Cerebral Circulation
Current Vascular Pharmacology Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair
CNS & Neurological Disorders - Drug Targets Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm
Current Drug Targets